Related Experiment Video
Updated: May 24, 2026
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells
Chunle Zhang1, Lingjun Liu, Yang Yu
1Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.
Abstract:
The antitumor effects of ginsenoside Rg3 have been reported in several kinds of human malignant tumors. The purpose of this study was to investigate whether ginsenoside Rg3 can inhibit the growth of human hepatocellular carcinoma cell lines and to discuss the possible molecular mechanism(s). We cultured the human hepatocellular carcinoma cell lines, SMMC-7721 and HepG2. The cells were treated with different concentrations of ginsenoside Rg3 (0, 25, 50, 75 and 100 µg/ml), and the cell proliferation was detected by MTT assay at the 12, 24, 36 and 48 h time-points. Flow cytometry experiments were carried out to investigate the effect of Rg3 on cell apoptosis after the cells had been treated with Rg3 (50 and 100 µg/ml) for 24 and 48 h. The expression levels of caspase-3, bax and bcl-2 in Rg3-treated cells (100 µg/ml, 48 h), as well as normal cells were detected through real-time PCR experiments. MTT assay showed that the inhibition rate of cell proliferation in the Rg3 groups was significantly higher compared to the control groups in both the SMMC-7721 and HepG2 cell lines, and the inhibition rate increased with increasing Rg3 concentrations and duration of treatment. Flow cytometry analysis demonstrated that the Rg3 groups had a significantly higher cell apoptotic rate compared to the control groups in both the SMMC-7721 and HepG2 cell lines, and that the effect of Rg3 on cell apoptosis occurred in a concentration- and time-dependent manner, as was also shown by the MTT assay. Real-time PCR analysis showed that the gene expression levels of caspase-3 and bax were significantly enhanced in the Rg3 groups compared to the control groups in both the SMMC-7721 and HepG2 cell lines, but the gene expression level of bcl-2 was significantly inhibited. These results indicate that ginsenoside Rg3 can effectively inhibit the growth of human hepatocellular carcinoma cell lines by inhibiting cancer cell proliferation and promoting cancer cell apoptosis, and it may promote cancer cell apoptosis via the endogenous mitochondrial-mediated caspase-dependent apoptotic pathway.
Insights
Ginsenoside Rg3 effectively inhibits human hepatocellular carcinoma cell growth by reducing proliferation and inducing apoptosis. This natural compound shows promise in cancer treatment by targeting key cell death pathways.
Area of Science:
- Pharmacology
- Oncology
- Molecular Biology
Background:
- Ginsenoside Rg3 exhibits antitumor properties across various human cancers.
- Hepatocellular carcinoma (HCC) remains a significant global health concern with limited treatment options.
Purpose of the Study:
- To evaluate the inhibitory effects of ginsenoside Rg3 on human hepatocellular carcinoma cell lines (SMMC-7721 and HepG2).
- To elucidate the molecular mechanisms underlying ginsenoside Rg3's anti-cancer activity in HCC.
Main Methods:
- Cell culture of SMMC-7721 and HepG2 human hepatocellular carcinoma cell lines.
- MTT assay to assess cell proliferation inhibition at various concentrations and time points.
- Flow cytometry to analyze cell apoptosis.
- Real-time PCR to quantify gene expression of caspase-3, bax, and bcl-2.
Main Results:
- Ginsenoside Rg3 significantly inhibited proliferation in both cell lines in a dose- and time-dependent manner.
- Flow cytometry revealed a significant increase in apoptosis rates in Rg3-treated cells.
- Real-time PCR indicated elevated caspase-3 and bax expression, with decreased bcl-2 expression, suggesting mitochondrial pathway involvement.
Conclusions:
- Ginsenoside Rg3 demonstrates potent anti-proliferative and pro-apoptotic effects against human hepatocellular carcinoma cells.
- The mechanism involves the mitochondrial-mediated, caspase-dependent apoptotic pathway.
- Ginsenoside Rg3 presents a potential therapeutic agent for hepatocellular carcinoma.